Winner Medical Co., Ltd. (SHE:300888)
China
· Delayed Price · Currency is CNY 34.25
+0.25 (0.74%)
Mar 10, 2026, 1:35 PM CST
Winner Medical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 19,799 | 24,504 | 21,889 | 30,011 | 35,164 | 70,798 | Upgrade
|
| Market Cap Growth | -7.86% | 11.95% | -27.06% | -14.65% | -50.33% | - | Upgrade
|
| Enterprise Value | 19,481 | 22,177 | 16,936 | 25,711 | 28,699 | 63,672 | Upgrade
|
| Last Close Price | 34.00 | 41.41 | 35.53 | 47.16 | 53.56 | 106.28 | Upgrade
|
| PE Ratio | 22.69 | 35.24 | 37.71 | 18.18 | 28.37 | 18.58 | Upgrade
|
| Forward PE | 19.01 | 26.38 | 11.53 | 18.04 | 17.13 | 28.43 | Upgrade
|
| PS Ratio | 1.83 | 2.73 | 2.67 | 2.64 | 4.38 | 5.65 | Upgrade
|
| PB Ratio | 1.61 | 2.06 | 1.81 | 2.46 | 3.29 | 6.76 | Upgrade
|
| P/TBV Ratio | 2.15 | 2.78 | 2.26 | 3.11 | 3.38 | 6.91 | Upgrade
|
| P/FCF Ratio | 26.44 | 67.16 | 70.55 | 16.82 | 273.82 | 16.88 | Upgrade
|
| P/OCF Ratio | 13.33 | 19.36 | 20.59 | 10.06 | 40.34 | 14.85 | Upgrade
|
| EV/Sales Ratio | 1.80 | 2.47 | 2.07 | 2.27 | 3.57 | 5.08 | Upgrade
|
| EV/EBITDA Ratio | 11.50 | 19.44 | 17.06 | 12.55 | 22.43 | 12.95 | Upgrade
|
| EV/EBIT Ratio | 17.76 | 28.04 | 25.01 | 14.43 | 25.79 | 13.38 | Upgrade
|
| EV/FCF Ratio | 26.02 | 60.78 | 54.59 | 14.41 | 223.48 | 15.18 | Upgrade
|
| Debt / Equity Ratio | 0.23 | 0.25 | 0.18 | 0.23 | 0.06 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 1.63 | 2.13 | 1.79 | 1.25 | 0.40 | 0.03 | Upgrade
|
| Debt / FCF Ratio | 3.69 | 7.97 | 7.02 | 1.59 | 4.66 | 0.04 | Upgrade
|
| Net Debt / Equity Ratio | -0.09 | -0.15 | -0.44 | -0.51 | -0.64 | -0.78 | Upgrade
|
| Net Debt / EBITDA Ratio | -0.74 | -1.55 | -5.42 | -3.01 | -5.36 | -1.66 | Upgrade
|
| Net Debt / FCF Ratio | -1.46 | -4.84 | -17.33 | -3.46 | -53.39 | -1.94 | Upgrade
|
| Asset Turnover | 0.59 | 0.51 | 0.46 | 0.72 | 0.61 | 1.43 | Upgrade
|
| Inventory Turnover | 2.82 | 2.88 | 2.94 | 4.02 | 2.93 | 4.72 | Upgrade
|
| Quick Ratio | 1.06 | 1.13 | 2.02 | 1.88 | 4.13 | 3.96 | Upgrade
|
| Current Ratio | 1.69 | 1.53 | 2.47 | 2.21 | 4.99 | 4.53 | Upgrade
|
| Return on Equity (ROE) | 7.63% | 6.18% | 5.17% | 14.63% | 11.70% | 56.08% | Upgrade
|
| Return on Assets (ROA) | 3.77% | 2.78% | 2.39% | 7.07% | 5.29% | 33.93% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.90% | 7.66% | 8.90% | 31.54% | 30.59% | 153.44% | Upgrade
|
| Return on Capital Employed (ROCE) | 8.10% | 6.00% | 5.30% | 14.00% | 9.90% | 45.00% | Upgrade
|
| Earnings Yield | 4.42% | 2.84% | 2.65% | 5.50% | 3.52% | 5.38% | Upgrade
|
| FCF Yield | 3.78% | 1.49% | 1.42% | 5.95% | 0.36% | 5.92% | Upgrade
|
| Dividend Yield | 1.46% | 1.57% | 1.41% | 2.88% | 1.68% | 1.69% | Upgrade
|
| Payout Ratio | 52.17% | 59.34% | 141.56% | 24.29% | 61.98% | 2.69% | Upgrade
|
| Buyback Yield / Dilution | 0.69% | 1.33% | -0.10% | 0.77% | -9.42% | -3.31% | Upgrade
|
| Total Shareholder Return | 2.14% | 2.90% | 1.31% | 3.65% | -7.74% | -1.61% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.